Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
A qualitative study
Bibliographic Data
Despite disproportionately high rates of Hepatitis C (HCV) among people who inject drugs (PWID) in low- and middle-income countries (LMICs), understanding of HCV-related knowledge, attitudes and perceived risk behaviours among this population remains limited. We aimed to elucidate knowledge, attitudes and experiences that could minimise transmission risk and maximise HCV treatment engagement among PWID in Kenya following the integration of HCV screening and education with needle and syringe programmes in drop-in-centres (DICs). We recruited 40 PWID with chronic HCV attending DICs in Nairobi and Coastal Kenya. Semi-structured interviews revealed a general understanding of HCV and awareness of HCV risk behaviours among participants; however, many felt limited control over their transmission risk due to factors such as 'local doctors', or individuals who perform a high volume of high-risk injections. Financial barriers, distance to clinic, poor health status and HCV-related stigma were all noted as barriers to HCV treatment. In conclusion, basic knowledge of and motivation for HCV treatment among PWID accessing DICs in Kenya was high; however, structural barriers and stigma complicate access to care. Local education programmes can address knowledge gaps, and behavioural and structural interventions can maximise the impact of HCV care in LMICs
Environmental health · Family medicine · Hepatitis C · Population · Psychiatry · Psychological intervention · Qualitative research · Stigma (botany · Transmission (telecommunications · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Immunology
Awareness of hepatitis C prevention and treatment and high-risk behaviors among the general population in Anhui Province
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya
Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings
Gender differences in social networks of women and men who inject drugs in Kenya
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Hepatitis C treatment access and uptake for people who inject drugs
Superspreading and the effect of individual variation on disease emergence
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
The Measurement of Observer Agreement for Categorical Data
Consolidated criteria for reporting qualitative research (Coreq)
A Coefficient of Agreement for Nominal Scales
Access to medicines and hepatitis C in Africa
Stigma and social barriers to medication adherence with urban youth living with HIV
Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents
Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women
Elimination of hepatitis C virus infection among people who use drugs
Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries
Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs
| Citations per year | 1.25 |
|---|---|
| Citation span | 2022 - 2026 (5) |
| Highly cited | No |